The Innovative Prosthetic Urology Portfolio From Rigicon Receives Marketing Approval in Australia
Rigicon is the manufacturer of innovative prosthetic urology devices.
RONKONKOMA, N.Y. - February 11, 2021 - (Newswire.com)
Rigicon Inc., with its global headquarters in NY, USA, announces that their innovative prosthetic urology portfolio received marketing approval from Australia (Australian Government Department of Health Therapeutic Goods Administration).
The following implant options from Rigicon are now available for specialized surgeons and patients in Australia:
- Infla10® Inflatable Penile Prosthesis Models
- Rigi10™ Malleable Penile Prosthesis
- Conti® Artificial Urinary Sphincter Models
- Testi10™ Testicular Prosthesis Models
With this approval, Rigicon becomes the first medical device solutions provider in the Australian market with a diverse and complete portfolio of men's health treatment options.
Rigicon will carry out its operations directly from its local headquarters located in Norwood, SA, to ensure sustainable access to Rigicon's high-quality treatment options and "customer-first" service mentality.
Rigicon will continue to invest in the Australian Economy by hiring local talent and investing in local facilities.
Rigicon is committed to increasing disease awareness for Erectile Dysfunction and Urinary Incontinence by developing patient-focused online/offline platforms and full cooperation with leading scientific communities in the region (i.e., The Urological Society of Australia and New Zealand (USANZ)) and globally (e.g., American Urological Association and the European Association of Urology).
Infla10® Inflatable Penile Prosthesis Model
Infla10® Anatomical Expansion model is the world's only inflatable penile prosthesis model that can offer girth and length expansion and a hydrophilic coating.
Rigi10™ Malleable Penile Prosthesis
Rigi10™ Malleable Penile Prosthesis is designed for the treatment of organic "erectile dysfunction" in men.
Conti® Artificial Urinary Sphincter Models
ContiClassic® Artificial Urinary Sphincter and ContiReflex® Artificial Urinary Sphincter are implant devices that treat Urinary Incontinence.
HydroShield™ Hydrophilic Coating
All components of the Infla10® Inflatable Penile Prostheses Models, Rigi10™ Malleable Penile Prosthesis, and Conti® Artificial Urinary Sphincter Systems are offered with the HydroShield™ hydrophilic coating, giving the physician freedom to choose the aqueous solution for dipping the devices before implantation.
Testi10™ Testicular Prosthesis Models
Testi10™ Testicular Prosthesis Models are indicated for patients diagnosed with testicular agenesis or patients whose testicle or testicles were surgically removed due to several pathologies. The prosthesis is also indicated for replacement.
About erectile dysfunction
Erectile dysfunction, or ED, is the inability to achieve or sustain an erection suitable for sexual intercourse. ED is a common male sexual disorder and may maintain a permanent course as some men cannot have an erection for the remaining part of their life.
ED may be caused by various diseases and disorders, including heart disease, diabetes, pelvic area damage due to surgery, accidents or radiation therapy, benign prostatic hyperplasia (BPH, which is a non-cancerous enlargement of the prostate tissue), disorders associated with low testosterone levels, and other neurologic diseases.
Rigicon is exclusively focused on designing, manufacturing, and marketing innovative pelvic urology solutions. Our mission is to be the one-stop source for a comprehensive portfolio of products and services and make high-quality innovative pelvic urology solutions accessible to all customers.
Find out more at firstname.lastname@example.org | www.rigicon.com.au | www.rigicon.com
Rigicon Australia Marketing Approval Press Release_02112021_V4.pdf
Press Release Service by Newswire.com
Original Source: The Innovative Prosthetic Urology Portfolio From Rigicon Receives Marketing Approval in Australia